With thanks to all who have invested in INSEAD for the next generation
Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. - Lancet - X-MOL
39217 PDFs and publications in INNOVATION PROCESS
Business Citizenship: From Domestic to Global Level of Analysis | Request PDF
Installing Git on Cygwin – Celinio's technical blog : learning and adapting
39217 PDFs and publications in INNOVATION PROCESS
Funen Blok K – Verdana | Jidipi
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.,The Lancet - X-MOL
Falleret millionærdatter: Sover i køkkenet - Avisen.dk
Catalogue - Go Short 2013 by Go Short - International Short Film Festival Nijmegen - issuu